A Case Report of Using Intravitreal Dexamethasone Implants as the Bridging Treatment for Ocular Manifestations in Susac Syndrome
In cases of delayed systemic immunosuppressive therapies, intravitreal dexamethasone can be considered as a bridging treatment for ocular manifestations of Susac syndrome.
Authors
- Elaine Tran (ORCID: https://orcid.org/0000-0001-8841-3595)
Institutions
- Kaiser Permanente (US)
- University of California System (US)
- University of California San Diego (US)
- Smith-Kettlewell Eye Research Institute (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1080/09273948.2025.2553217
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00